PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC8412326::ACT051946

FCLYELAR

Evidence text

Paper-level observation

In the case of the FCLYELAR peptide, Ki measured a constant 0.0248 mM as shown in Fig 6.
textConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
Ki
Comparator
=
Raw observation
0.0248 mM
Normalized measurement
=0.0248 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Oryctolagus cuniculus
Assay method
Not reported by source
Sequence
FCLYELAR
Standardization
ready simple

Source publication

A novel angiotensin I-converting enzyme inhibitory peptide derived from the trypsin hydrolysates of salmon bone proteins

PLoS ONE · 2021

DOI 10.1371/journal.pone.0256595 PMC8412326
Parent mention

Related peptide identities

PEPDIA-PLP-000669

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.